EPO and type 2 diabetes mellitus: Considering that we have information on the presence or absence of DME for 139 out of the 302 T2DM patients enrolled between 2015 and 2017, an exploratory analysis was performed to examine the potential association of the three EPO polymorphisms with this retinal complication.